168 results
DEFA14A
ATRA
Atara Biotherapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:20pm
as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. For 4. To approve the Company’s 2024 Equity
424B5
e68pkwhkmhrqcy5uxw
9 Jan 24
Prospectus supplement for primary offering
4:28pm
8-K
EX-5.1
5tutbz1h
9 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
9nx1z i7b595ubiu90f
9 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
8x87mu7s l8mqjbwfu
8 Jan 24
Cost Associated with Exit or Disposal Activities
8:11am
S-8
EX-5.1
zmkaqn6o
3 Jan 24
Registration of securities for employees
4:09pm
S-8
vm55wu
3 Jan 24
Registration of securities for employees
4:09pm
S-8
EX-23.2
o77i3nea5if86xe
3 Jan 24
Registration of securities for employees
4:09pm
424B3
cp27sow7e7j4wqv
17 Nov 23
Prospectus supplement
4:31pm
8-K
EX-1.1
nx4mffuqpv3wbj6icit
1 Nov 23
Other Events
4:05pm